- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07831525
Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects (CURRENT-Flow)
Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects: A Randomized Clinical Trial
Transcranial modulation of the corticospinal sensorimotor pathway is a promising approach in neuroscientic functions. Among the techniques used, transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS) and the application of random noise current stand out. Objective: To compare the e stimulus, in the EEG frequency bands, on Motor Evoked Potentials (MEP) and on the functional activation of the motor cortex, assessed by Functional Near Infrared Spectroscopy (fNIRS) and pain measurements in healthy subjects subjected to a standardized algogenic stimulus. Subjects and Method: This is a randomized, double-blind, controlled and crossover clinical trial, involving the inclusion of 14 healthy male subjects, with complete secondary education, aged between 18 and 40. years. Participants will be randomized to receive Transcranial Direct Current Stimulation (tDCS), (2) Transcranial Alternating Current Stimulation (tACs), (3) Random Noise Current, (4) Simulated Stimulation Session and (5) Rest Session. Experimental conditions will take place in a standard, quiet and bright room. Assessments will include Motor Evoked Potential, Heat Pain Threshold, Motor Area Activation through metabolic activation measured by fNIRS and analysis of EEG frequency waves. After the baseline assessment, participants will undergo a session of transcranial stimulation, followed by an algogenic stimulus with water at zero degrees, immersion of the dominant hand for 1 minute, with rest intervals of 3 minutes between each of the four serial stimuli. After this stimulus session, outcome measurements will be carried out. Expected results: This clinical trial is expected to provide insights into how tDCS, tACs and random stimulation in to an algogenic stimulus. The results may contribute to the development of therapeutic or neuromodulation strategies in clinical conditions where the regulation of the cortico-spinal sensorimotor pathway is relevant.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien
- Hospital de Clinicas de Porto Alegre
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Healthy male subjects aged 18-45 years, with at least a high school diploma, and not engaged in night-shift work.
Exclusion Criteria:
- Contraindications to transcranial stimulation include implanted medical devices in the brain, cardiac pacemakers, and cochlear implants.
- Current use of psychotropic medications.
- History of alcohol or substance abuse within the past 6 months.
- Neurological disorders, history of traumatic brain injury, or prior neurosurgery.
- Beck Depression Inventory-II (BDI-II) score >13.
- Self-Reporting Questionnaire (SRQ) score >7.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Transcranial Direct Current Stimulation (tDCS) over motor area (M1)
Participants receive active transcranial direct current stimulation over the primary motor cortex (M1) during the intervention sessions. |
Stimulation is delivered using two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The electrodes are positioned on the scalp according to the international 10-20 system. The anode is placed at position C3 (left primary motor cortex, M1) and the cathode over the ipsilateral clavicular region. The sinusoidal current intensity per channel ranges from ±2 mA. The session duration is 20 minutes.
Andre navne:
|
|
Aktiv komparator: Transcranial Alternating Current Stimulation (tACS) over M1
Participants receive active transcranial alternating current stimulation over the primary motor cortex (M1) during the intervention sessions. |
Single session of active gamma transcranial alternating current stimulation delivered for 30 minutes using a battery-powered external stimulator. Stimulation is applied through two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The stimulation frequency is 40 Hz, based on previous gamma-band transcranial alternating current stimulation (tACS) studies. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region.
Andre navne:
|
|
Aktiv komparator: Transcranial Random Noise Stimulation (tRNS) over M1
Participants receive active transcranial random noise stimulation over the primary motor cortex (M1) during the intervention sessions. |
Stimulation is delivered using two sponge electrodes mounted on a neoprene cap. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region. A random current level is generated for each sample at a sampling rate of 1280 samples per second. The random values are normally distributed, following a bell-shaped probability density function. The noise signal contains all frequencies up to half the sampling rate (maximum 640 Hz) and has no DC offset.
Andre navne:
|
|
Sham-komparator: Sham Stimulation
Participants undergo sham stimulation, experiencing the same setup as active stimulation without actual current delivery. |
During the sham stimulation session, the tDCS device ramps up the current to 2 mA over 30 seconds and then is immediately turned off. This procedure mimics the sensations of active stimulation without delivering therapeutic current for the remainder of the session.
Andre navne:
|
|
Ingen indgriben: Rest State
Participants remain seated with their eyes open for 20 minutes during the rest session, without performing any other task. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Resting-State EEG Power Spectra Across Frequency Bands (Delta, Theta, Alpha, Beta 1, Beta 2, and Gamma)
Tidsramme: Immediately before and immediately after the intervention.
|
Electroencephalography (EEG) will be used to quantify neuronal activity through quantitative EEG (qEEG) analysis. Resting-state EEG power spectra will be analyzed across delta, theta, alpha, beta, and gamma frequency bands, reflecting synchronized neuronal oscillations. EEG data will be recorded using a 20-electrode montage according to the international 10-20 system during an 8-minute resting-state paradigm with alternating eyes-open and eyes-closed conditions. Cortical source localization will be performed using standardized Low-Resolution Brain Electromagnetic Tomography (sLORETA). |
Immediately before and immediately after the intervention.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Corticospinal Excitability
Tidsramme: Immediately before and immediately after the intervention.
|
Corticospinal excitability will be assessed using single-pulse transcranial magnetic stimulation (TMS) applied over the left primary motor cortex. Motor evoked potentials (MEPs) will be recorded from the right first dorsal interosseous muscle, and measures will include resting motor threshold (RMT) and MEP amplitude, with MEPs obtained at 130% of the motor threshold. |
Immediately before and immediately after the intervention.
|
|
Motor Cortex Functional Connectivity
Tidsramme: Immediately before and immediately after the intervention.
|
Functional connectivity of the motor cortex will be assessed using functional near-infrared spectroscopy (fNIRS) with a continuous-wave NirScout® system. Optodes will be positioned according to the international 10-10 system to cover the bilateral motor cortex. Data will be acquired during resting-state conditions and during the cold pressor task. Functional connectivity will be analyzed within predefined motor cortex regions of interest. |
Immediately before and immediately after the intervention.
|
|
Heat Pain Threshold
Tidsramme: Immediately before and immediately after the intervention.
|
Heat pain threshold will be assessed via quantitative sensory testing (QST) on the left forearm using a thermode that increases temperature from 30°C to 52°C at a rate of 1°C per second. The pain threshold is calculated as the average temperature at which pain is first reported across three trials. Higher values indicate greater pain threshold. |
Immediately before and immediately after the intervention.
|
|
Function of the Descending Pain Inhibitory System
Tidsramme: Immediately before and immediately after the intervention.
|
The function of the descending pain inhibitory system will be assessed using the Conditioned Pain Modulation Test (CPM-test). Pain intensity is rated using a verbal numerical rating scale (0 = no pain to 10 = worst possible pain) before (T0) and during (T1) cold-water immersion. The CPM effect is calculated as the difference between pain ratings at T0 and T1, with greater reductions indicating more effective pain inhibition. |
Immediately before and immediately after the intervention.
|
|
Cold Pressor Test Pain Tolerance
Tidsramme: Immediately before and immediately after the intervention.
|
Pain intensity and tolerance will be assessed using the Cold Pressor Test, in which participants immerse the non-dominant hand in ice-saturated water (~1°C) for up to 2 minutes. Pain intensity will be continuously rated using an electronic visual analog scale, allowing calculation of peak pain, mean pain, and area under the curve (AUC) over the test duration. |
Immediately before and immediately after the intervention.
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 81182524.7.0000.5327
- 20240121 (Anden identifikator: HCPA)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Data will be available upon request at wcaumo@hcpa.edu.br after 6 months of publication.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .